| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Astrocytes | 15 | 2022 | 255 | 1.550 |
Why?
|
| Manganese | 12 | 2024 | 87 | 1.530 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 11 | 2021 | 38 | 1.460 |
Why?
|
| Ovarian Neoplasms | 9 | 2016 | 312 | 1.440 |
Why?
|
| Chemokines | 4 | 2013 | 97 | 1.400 |
Why?
|
| NF-kappa B | 11 | 2017 | 339 | 1.370 |
Why?
|
| Granulosa Cells | 5 | 2010 | 42 | 1.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 11 | 2024 | 356 | 1.140 |
Why?
|
| Up-Regulation | 8 | 2024 | 513 | 1.140 |
Why?
|
| YY1 Transcription Factor | 6 | 2022 | 18 | 1.040 |
Why?
|
| Disease Progression | 4 | 2024 | 601 | 1.040 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2016 | 20 | 1.030 |
Why?
|
| Soil | 3 | 2022 | 130 | 0.980 |
Why?
|
| Fasting | 1 | 2024 | 54 | 0.960 |
Why?
|
| Cell Cycle | 2 | 2024 | 326 | 0.940 |
Why?
|
| Plants | 3 | 2022 | 99 | 0.900 |
Why?
|
| Manganese Poisoning | 4 | 2023 | 22 | 0.760 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 6 | 2020 | 16 | 0.750 |
Why?
|
| Promoter Regions, Genetic | 12 | 2021 | 515 | 0.690 |
Why?
|
| Ecosystem | 1 | 2020 | 123 | 0.660 |
Why?
|
| Mice | 23 | 2024 | 5913 | 0.650 |
Why?
|
| Estradiol | 6 | 2024 | 262 | 0.640 |
Why?
|
| Orosomucoid | 6 | 2001 | 12 | 0.630 |
Why?
|
| Chemokine CXCL1 | 4 | 2016 | 15 | 0.630 |
Why?
|
| I-kappa B Kinase | 2 | 2021 | 44 | 0.610 |
Why?
|
| Serum Amyloid A Protein | 2 | 2010 | 14 | 0.610 |
Why?
|
| Animals | 42 | 2024 | 15081 | 0.600 |
Why?
|
| Environmental Pollutants | 5 | 2004 | 179 | 0.590 |
Why?
|
| Chemokine CCL20 | 1 | 2016 | 7 | 0.580 |
Why?
|
| Obesity | 1 | 2024 | 1067 | 0.540 |
Why?
|
| Cyclooxygenase 1 | 3 | 2015 | 11 | 0.520 |
Why?
|
| Repressor Proteins | 4 | 2022 | 249 | 0.510 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 114 | 0.500 |
Why?
|
| Chemokines, CXC | 2 | 2022 | 35 | 0.490 |
Why?
|
| Depsipeptides | 2 | 2010 | 7 | 0.440 |
Why?
|
| Swine | 7 | 2001 | 184 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 269 | 0.430 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 2231 | 0.420 |
Why?
|
| Signal Transduction | 11 | 2017 | 1908 | 0.420 |
Why?
|
| Protein Isoforms | 2 | 2010 | 130 | 0.410 |
Why?
|
| Microglia | 3 | 2024 | 166 | 0.410 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 123 | 0.400 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2015 | 37 | 0.390 |
Why?
|
| Swine, Miniature | 3 | 2000 | 8 | 0.380 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 213 | 0.370 |
Why?
|
| Chemotactic Factors | 2 | 2007 | 7 | 0.370 |
Why?
|
| Ovary | 7 | 2010 | 108 | 0.370 |
Why?
|
| Female | 24 | 2024 | 20969 | 0.370 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 9 | 0.370 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 55 | 0.360 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2010 | 623 | 0.360 |
Why?
|
| Aspirin | 1 | 2010 | 49 | 0.360 |
Why?
|
| Cyclic AMP | 2 | 2010 | 131 | 0.350 |
Why?
|
| Blotting, Western | 8 | 2012 | 859 | 0.340 |
Why?
|
| Cells, Cultured | 12 | 2021 | 1518 | 0.340 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2004 | 34 | 0.340 |
Why?
|
| Cell Proliferation | 5 | 2024 | 1198 | 0.340 |
Why?
|
| Inflammation | 3 | 2024 | 618 | 0.330 |
Why?
|
| Anti-Infective Agents | 2 | 2000 | 64 | 0.320 |
Why?
|
| Valproic Acid | 2 | 2018 | 16 | 0.310 |
Why?
|
| Transforming Growth Factor alpha | 4 | 2017 | 22 | 0.310 |
Why?
|
| Cell Movement | 3 | 2024 | 571 | 0.300 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 578 | 0.290 |
Why?
|
| Trimethoprim | 3 | 1996 | 6 | 0.290 |
Why?
|
| Tamoxifen | 3 | 2017 | 65 | 0.280 |
Why?
|
| Antigens, CD | 2 | 2004 | 121 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 9 | 2018 | 1609 | 0.280 |
Why?
|
| RNA, Messenger | 8 | 2020 | 1207 | 0.280 |
Why?
|
| Interleukin-1alpha | 1 | 2006 | 18 | 0.280 |
Why?
|
| Carcinoma | 1 | 2007 | 96 | 0.280 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 1015 | 0.270 |
Why?
|
| Humans | 20 | 2024 | 37093 | 0.260 |
Why?
|
| Ovulation | 4 | 2002 | 20 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2010 | 1039 | 0.250 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2002 | 48 | 0.240 |
Why?
|
| Oxidative Stress | 5 | 2024 | 938 | 0.240 |
Why?
|
| Mice, Obese | 1 | 2024 | 40 | 0.240 |
Why?
|
| Sp1 Transcription Factor | 1 | 2024 | 48 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 306 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 26 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 807 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 5 | 2012 | 502 | 0.230 |
Why?
|
| Serum Albumin | 5 | 2001 | 50 | 0.220 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2020 | 78 | 0.220 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2002 | 51 | 0.220 |
Why?
|
| Yin-Yang | 1 | 2022 | 2 | 0.220 |
Why?
|
| Svalbard | 1 | 2022 | 1 | 0.220 |
Why?
|
| Republic of Korea | 2 | 2020 | 107 | 0.220 |
Why?
|
| Coal | 1 | 2022 | 10 | 0.220 |
Why?
|
| Estriol | 1 | 2002 | 9 | 0.210 |
Why?
|
| Brain | 3 | 2022 | 1346 | 0.210 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2010 | 21 | 0.210 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2002 | 23 | 0.210 |
Why?
|
| Soil Microbiology | 1 | 2022 | 49 | 0.210 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 59 | 0.210 |
Why?
|
| Lincomycin | 3 | 2001 | 3 | 0.210 |
Why?
|
| Clindamycin | 3 | 2001 | 13 | 0.200 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 171 | 0.200 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 159 | 0.200 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 461 | 0.200 |
Why?
|
| Blotting, Northern | 3 | 2010 | 150 | 0.190 |
Why?
|
| Ofloxacin | 1 | 2000 | 6 | 0.190 |
Why?
|
| Substantia Nigra | 1 | 2020 | 44 | 0.180 |
Why?
|
| Mice, Nude | 2 | 2022 | 337 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 3 | 2001 | 352 | 0.180 |
Why?
|
| Theca Cells | 1 | 1999 | 4 | 0.180 |
Why?
|
| Histone Deacetylases | 4 | 2020 | 56 | 0.170 |
Why?
|
| Steroids | 1 | 1999 | 43 | 0.170 |
Why?
|
| Neuroprotective Agents | 2 | 2024 | 245 | 0.170 |
Why?
|
| Bacteria | 1 | 2022 | 255 | 0.170 |
Why?
|
| Biodiversity | 1 | 2020 | 83 | 0.170 |
Why?
|
| Erigeron | 1 | 2018 | 1 | 0.160 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 539 | 0.160 |
Why?
|
| RNA, Small Interfering | 4 | 2013 | 409 | 0.160 |
Why?
|
| Conservation of Natural Resources | 1 | 2018 | 35 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2016 | 1618 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2014 | 86 | 0.150 |
Why?
|
| Apoptosis | 3 | 2022 | 1398 | 0.150 |
Why?
|
| Transcriptional Activation | 2 | 2020 | 172 | 0.150 |
Why?
|
| Protein Binding | 7 | 2020 | 972 | 0.150 |
Why?
|
| Cell Line | 4 | 2024 | 1354 | 0.150 |
Why?
|
| Caprylates | 1 | 2017 | 11 | 0.150 |
Why?
|
| Butyric Acid | 1 | 2017 | 18 | 0.150 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 893 | 0.150 |
Why?
|
| Sulfonamides | 1 | 1997 | 80 | 0.150 |
Why?
|
| Peritoneal Cavity | 1 | 2016 | 6 | 0.140 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2014 | 32 | 0.140 |
Why?
|
| Rats | 9 | 2016 | 3483 | 0.140 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 90 | 0.140 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 1996 | 2 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 168 | 0.140 |
Why?
|
| Dopamine | 1 | 2018 | 245 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 173 | 0.140 |
Why?
|
| Actinobacillus Infections | 1 | 1996 | 3 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2016 | 136 | 0.140 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1996 | 7 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 251 | 0.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2013 | 54 | 0.140 |
Why?
|
| Swine Diseases | 1 | 1996 | 5 | 0.140 |
Why?
|
| Pregnancy, Animal | 1 | 1996 | 16 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 803 | 0.140 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 219 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 40 | 0.130 |
Why?
|
| Transfection | 1 | 2016 | 523 | 0.130 |
Why?
|
| Motor Activity | 1 | 2017 | 418 | 0.120 |
Why?
|
| Blood Proteins | 1 | 1994 | 66 | 0.120 |
Why?
|
| Ovarian Follicle | 2 | 2005 | 35 | 0.110 |
Why?
|
| Time Factors | 4 | 2006 | 1742 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2012 | 61 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 40 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2020 | 933 | 0.110 |
Why?
|
| Ligands | 1 | 2013 | 349 | 0.110 |
Why?
|
| Aging | 2 | 1995 | 664 | 0.110 |
Why?
|
| Gene Deletion | 2 | 2022 | 166 | 0.110 |
Why?
|
| Models, Biological | 4 | 2014 | 677 | 0.100 |
Why?
|
| Cell Division | 2 | 2003 | 307 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 626 | 0.100 |
Why?
|
| Injections, Intravenous | 3 | 2001 | 62 | 0.100 |
Why?
|
| Area Under Curve | 3 | 2001 | 88 | 0.100 |
Why?
|
| Gene Silencing | 2 | 2012 | 151 | 0.090 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2010 | 1 | 0.090 |
Why?
|
| Aromatase | 1 | 2010 | 19 | 0.090 |
Why?
|
| src-Family Kinases | 2 | 2013 | 46 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2010 | 129 | 0.090 |
Why?
|
| Base Sequence | 3 | 2020 | 997 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2004 | 384 | 0.090 |
Why?
|
| Drug Synergism | 1 | 2010 | 177 | 0.090 |
Why?
|
| Kinetics | 2 | 2004 | 708 | 0.090 |
Why?
|
| RNA Interference | 1 | 2010 | 243 | 0.080 |
Why?
|
| Glutamic Acid | 2 | 2021 | 128 | 0.080 |
Why?
|
| Locomotion | 2 | 2020 | 97 | 0.080 |
Why?
|
| Erythromycin | 3 | 2001 | 13 | 0.080 |
Why?
|
| Gene Expression | 2 | 2018 | 674 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 169 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 152 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2007 | 433 | 0.080 |
Why?
|
| Binding Sites | 2 | 2013 | 651 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 2007 | 35 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2007 | 112 | 0.070 |
Why?
|
| Chemokine CXCL2 | 1 | 2006 | 11 | 0.070 |
Why?
|
| Endotoxins | 1 | 2006 | 18 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 90 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2006 | 207 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 220 | 0.070 |
Why?
|
| Estrogen Receptor alpha | 2 | 2017 | 111 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2004 | 161 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2021 | 928 | 0.060 |
Why?
|
| Male | 7 | 2020 | 20025 | 0.060 |
Why?
|
| Reproduction | 1 | 2005 | 71 | 0.060 |
Why?
|
| Mutation | 2 | 2023 | 1095 | 0.060 |
Why?
|
| Response Elements | 2 | 2015 | 56 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2004 | 41 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2004 | 89 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 1 | 2003 | 35 | 0.060 |
Why?
|
| Acetylation | 2 | 2007 | 98 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2004 | 120 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 290 | 0.050 |
Why?
|
| Dioxins | 1 | 2002 | 8 | 0.050 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2002 | 2 | 0.050 |
Why?
|
| Enzyme Induction | 1 | 2002 | 53 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 58 | 0.050 |
Why?
|
| Luciferases | 1 | 2002 | 63 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2002 | 36 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 515 | 0.050 |
Why?
|
| Inhibins | 1 | 2002 | 5 | 0.050 |
Why?
|
| Teratogens | 1 | 2002 | 11 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 41 | 0.050 |
Why?
|
| Autophagy | 1 | 2023 | 116 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 189 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 105 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2002 | 158 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2021 | 49 | 0.050 |
Why?
|
| Serine | 1 | 2021 | 75 | 0.050 |
Why?
|
| Manganese Compounds | 1 | 2020 | 16 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 197 | 0.050 |
Why?
|
| Chlorides | 1 | 2020 | 56 | 0.050 |
Why?
|
| Age Factors | 1 | 2003 | 1033 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2002 | 681 | 0.050 |
Why?
|
| CREB-Binding Protein | 1 | 2020 | 13 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 286 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2002 | 145 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2020 | 51 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 70 | 0.040 |
Why?
|
| DNA | 1 | 2002 | 574 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 77 | 0.040 |
Why?
|
| Cell Survival | 2 | 2017 | 864 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 1180 | 0.040 |
Why?
|
| Chorionic Gonadotropin | 3 | 2005 | 15 | 0.040 |
Why?
|
| Ecology | 1 | 2018 | 22 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 435 | 0.040 |
Why?
|
| Luteinizing Hormone | 3 | 2005 | 63 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2001 | 421 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2018 | 34 | 0.040 |
Why?
|
| Sulfamethazine | 1 | 1997 | 1 | 0.040 |
Why?
|
| Sulfamonomethoxine | 1 | 1997 | 1 | 0.040 |
Why?
|
| Sulfadiazine | 1 | 1997 | 4 | 0.040 |
Why?
|
| Sheep | 1 | 1998 | 72 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 2017 | 41 | 0.040 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2017 | 11 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2017 | 105 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2017 | 77 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 14 | 0.040 |
Why?
|
| Dogs | 1 | 1998 | 149 | 0.040 |
Why?
|
| Species Specificity | 1 | 1998 | 245 | 0.040 |
Why?
|
| Catalase | 1 | 2017 | 109 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2017 | 107 | 0.040 |
Why?
|
| Cerebellum | 1 | 2017 | 73 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 93 | 0.040 |
Why?
|
| Glutathione | 1 | 2017 | 179 | 0.040 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 1996 | 1 | 0.040 |
Why?
|
| Cattle | 1 | 1998 | 477 | 0.030 |
Why?
|
| Neuraminic Acids | 1 | 1996 | 1 | 0.030 |
Why?
|
| Actinobacillus pleuropneumoniae | 1 | 1996 | 1 | 0.030 |
Why?
|
| Pregnancy | 2 | 2005 | 1549 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 617 | 0.030 |
Why?
|
| Quinazolines | 1 | 2016 | 33 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 181 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 208 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 602 | 0.030 |
Why?
|
| Genome, Human | 1 | 2015 | 135 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 127 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 1994 | 25 | 0.030 |
Why?
|
| Estrogen Receptor beta | 1 | 2014 | 40 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 40 | 0.030 |
Why?
|
| Cell Extracts | 1 | 2013 | 16 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 73 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2005 | 43 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 76 | 0.030 |
Why?
|
| Japan | 1 | 1994 | 305 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 293 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 156 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2012 | 100 | 0.030 |
Why?
|
| DNA Primers | 1 | 2012 | 286 | 0.020 |
Why?
|
| Sexual Maturation | 2 | 2002 | 23 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 448 | 0.020 |
Why?
|
| Observer Variation | 1 | 2007 | 52 | 0.020 |
Why?
|
| Adult | 2 | 2007 | 11712 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2007 | 21 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2007 | 11 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2007 | 15 | 0.020 |
Why?
|
| Butyrates | 1 | 2007 | 31 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2007 | 32 | 0.020 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2007 | 35 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 84 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2007 | 44 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 173 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 550 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 661 | 0.020 |
Why?
|
| Anovulation | 1 | 2005 | 4 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2005 | 50 | 0.020 |
Why?
|
| Estrous Cycle | 1 | 2005 | 35 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2004 | 18 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 325 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 444 | 0.010 |
Why?
|
| Plasminogen Inactivators | 1 | 2002 | 3 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 2002 | 5 | 0.010 |
Why?
|
| Hypophysectomy | 1 | 2002 | 4 | 0.010 |
Why?
|
| Ribosomal Proteins | 1 | 2002 | 21 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2002 | 65 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2002 | 34 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 104 | 0.010 |
Why?
|
| Progesterone | 1 | 2002 | 113 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2002 | 224 | 0.010 |
Why?
|
| Estrus | 1 | 1999 | 14 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2002 | 517 | 0.010 |
Why?
|
| Aged | 1 | 2007 | 6741 | 0.010 |
Why?
|
| Middle Aged | 1 | 2007 | 10129 | 0.010 |
Why?
|